Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication

Clinical trial NCT05509998 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05509998
Sponsor: Icahn School of Medicine at Mount Sinai
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

First Episode Psychosis (FEP)Clinical High Risk for Psychosis (CHR)

Start date: 2023-05-01
Primary completion: 2027-04-30
Enrollment: 912

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.